Strategic Targeting & Field Insights Leader

Novartis AG; East Hanover (NJ); Hybrid; USD 186,000 - 345,000; Full time

Job summary

Novartis seeks an experienced leader to drive Insights and Analytics in East Hanover, NJ, with hybrid work options. You will shape US targeting and field engagement strategies for commercial teams, leveraging data science to enable smarter, data-driven decisions and stronger market penetration.

The role requires collaboration with I&A, CRM, and field teams, guiding NBA priorities and developing Next Best Action models while traveling up to 15% and aligning with regulatory requirements.

Qualifications

• Advanced degree in Business Administration, Data Science, Analytics, or related field.
• 8+ years of experience in customer prioritization, analytics, or strategic planning within pharma/healthcare.
• Proven track record in developing and implementing strategic goals for large field teams.
• Excellent analytical and communication skills with senior leadership collaboration.

Responsibilities

• Maintain and optimize targeting strategy for Novartis field teams.
• Identify and propagate effective targeting methods across teams.
• Prioritize accounts/HCPs for field engagement based on reimbursement trends and access.
• Develop call plans balancing workload across field force.
• Support NBA reviews and CRM/Field operations alignment.

Skills

Business Analytics

Forecasting

Data Analysis

Market Research

Customer Insights

Cross-Functional Collaboration

Strategic Planning

Leadership

Education

Advanced degree in Business Administration, Data Science, Analytics, or related field

Job description

Novartis seeks an experienced leader to drive Insights and Analytics in East Hanover, NJ, with hybrid work options. You will shape US targeting and field engagement strategies for commercial teams, leveraging data science to enable smarter, data-driven decisions and stronger market penetration.

The role requires collaboration with I&A, CRM, and field teams, guiding NBA priorities and developing Next Best Action models while traveling up to 15% and aligning with regulatory requirements.